It is administered in a single treatment, which will cost $450,000, which Novartis said is cheaper than some bone marrow transplants, and Novartis will not charge patients who don't respond.
Novartis says it will not charge patients who don't respond. It is administered in a single treatment, which will cost $450,000, which Novartis said is cheaper than some bone marrow transplants.
It is administered in a single treatment, which will cost $450,000, which Novartis said is cheaper than some bone marrow transplants. Novartis says it will not charge patients who don't respond.
It is administered in a single treatment, which will cost $450,000, which Novartis said is cheaper than some bone marrow transplants. Novartis says it will not charge patients who don't respond.